Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Sylebra Capital LimitedUnternehmen | -55,67k | 8,35M | Verkauf | 144,29 - 150,78 | 966,50k | -5,45% |
| 2026-05-28 | Mr. Miron L. WashingtonIndependent Director | 3,11k | 0,00 | Derivative Exercise and Retained Stock | - | 5,15k | 152,65% |
| 2026-05-28 | Mr. Umesh PadvalIndependent Director | 3,11k | 0,00 | Derivative Exercise and Retained Stock | - | 6,65k | 87,97% |
| 2026-05-28 | Ms. Meera P. RaoIndependent Director | 3,11k | 0,00 | Derivative Exercise and Retained Stock | - | 11,32k | 37,94% |
| 2026-05-08 | Sylebra Capital LimitedUnternehmen | -73,81k | 11,31M | Verkauf | 149,97 - 154,46 | 1,02M | -6,73% |
| 2026-05-07 | Sylebra Capital LimitedUnternehmen | -72,34k | 11,05M | Verkauf | 152,73 | 1,10M | -6,19% |
| 2026-03-23 | Mr. Cary L. BakerCFO | 1,13k | 0,00 | Derivative Exercise and Retained Stock | - | 89,00k | 1,28% |
| 2026-03-23 | Mr. Cary L. BakerCFO | -732,00 | 74,06k | Derivative Exercise and Sale | 101,17 | 89,00k | - |
| 2026-03-23 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | 3,42k | 0,00 | Derivative Exercise and Retained Stock | - | 589,66k | 0,58% |
| 2026-03-23 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -2,22k | 224,40k | Derivative Exercise and Sale | 101,17 | 589,66k | - |
| 2026-02-20 | Mr. Cary L. BakerCFO | -2,23k | 285,77k | Sale to Issuer | 127,92 | 87,88k | -2,48% |
| 2026-02-20 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -7,44k | 951,09k | Sale to Issuer | 127,92 | 586,25k | -1,25% |
| 2026-02-17 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -1,84k | 0,00 | Other Disposition | - | 571,95k | -0,32% |
| 2025-12-23 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | 3,42k | 0,00 | Derivative Exercise and Retained Stock | - | 573,78k | 0,60% |
| 2025-12-23 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -2,22k | 381,47k | Derivative Exercise and Sale | 171,99 | 573,78k | - |
| 2025-12-23 | Mr. Cary L. BakerCFO | 1,12k | 0,00 | Derivative Exercise and Retained Stock | - | 81,60k | 1,40% |
| 2025-12-23 | Mr. Cary L. BakerCFO | -732,00 | 125,90k | Derivative Exercise and Sale | 171,99 | 81,60k | - |
| 2025-12-11 | Sylebra Capital LimitedUnternehmen | -280,55k | 42,23M | Verkauf | 146,62 - 152,87 | 1,13M | -19,86% |
| 2025-12-08 | Sylebra Capital LimitedUnternehmen | -87,14k | 13,56M | Verkauf | 155,49 - 160,72 | 1,41M | -5,81% |
| 2025-12-03 | Sylebra Capital LimitedUnternehmen | -45,76k | 7,65M | Verkauf | 160,59 - 167,97 | 1,50M | -2,96% |
| 2025-12-01 | Sylebra Capital LimitedUnternehmen | -72,93k | 12,23M | Verkauf | 167,02 - 168,23 | 1,55M | -4,51% |
| 2025-11-26 | Sylebra Capital LimitedUnternehmen | -56,85k | 9,79M | Verkauf | 171,80 - 172,62 | 1,62M | -3,39% |
| 2025-11-24 | Sylebra Capital LimitedUnternehmen | -78,06k | 12,83M | Verkauf | 159,42 - 167,73 | 1,68M | -4,45% |
| 2025-11-25 | Mr. Cary L. BakerCFO | -1.000,00 | 0,00 | Other Disposition | - | 80,48k | -1,23% |
| 2025-11-20 | Sylebra Capital LimitedUnternehmen | -11,13k | 1,74M | Verkauf | 155,10 - 156,32 | 1,75M | -0,63% |
| 2025-11-19 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -7,00k | 0,00 | Other Disposition | - | 570,37k | -1,21% |
| 2025-11-12 | Sylebra Capital LimitedUnternehmen | -3,77k | 589,56k | Verkauf | 156,30 | 1,76M | -0,21% |
| 2025-11-11 | Sylebra Capital LimitedUnternehmen | -30,00k | 4,67M | Verkauf | 155,63 | 1,77M | -1,67% |
| 2025-11-07 | Sylebra Capital LimitedUnternehmen | -6,25k | 1,01M | Verkauf | 162,16 | 1,80M | -0,35% |
| 2025-11-06 | Sylebra Capital LimitedUnternehmen | -23,16k | 3,98M | Verkauf | 171,95 | 1,80M | -1,27% |
| 2025-11-07 | Mr. Miron L. WashingtonIndependent Director | -342,00 | 54,36k | Verkauf | 158,94 | 2,04k | -14,36% |
| 2025-11-03 | Sylebra Capital LimitedUnternehmen | -1,51k | 305,64k | Verkauf | 202,01 | 1,83M | -0,08% |
| 2025-10-30 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | 23,50k | 526,40k | Derivative Exercise and Retained Stock | 22,40 | 577,37k | 4,24% |
| 2025-09-23 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | 3,42k | 0,00 | Derivative Exercise and Retained Stock | - | 553,87k | 0,62% |
| 2025-09-23 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -2,22k | 410,45k | Derivative Exercise and Sale | 184,97 | 553,87k | - |
| 2025-09-23 | Mr. Cary L. BakerCFO | 1,13k | 0,00 | Derivative Exercise and Retained Stock | - | 81,48k | 1,40% |
| 2025-09-23 | Mr. Cary L. BakerCFO | -732,00 | 135,40k | Derivative Exercise and Sale | 184,97 | 81,48k | - |
| 2025-09-18 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | 54,08k | 1,75M | Derivative Exercise and Retained Stock | 22,40 - 33,77 | 550,45k | 10,89% |
| 2025-09-15 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -9,10k | 1,68M | Automatic Disposition | 179,26 - 191,76 | 496,38k | -1,80% |
| 2025-09-12 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -30,00k | 0,00 | Other Disposition | - | 496,38k | -5,70% |
| 2025-09-10 | Sylebra Capital LimitedUnternehmen | -300,00k | 58,87M | Verkauf | 196,24 | 1,83M | -14,09% |
| 2025-09-08 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -10,00k | 1,94M | Automatic Disposition | 190,42 - 199,77 | 535,47k | -1,83% |
| 2025-09-02 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -10,00k | 1,85M | Automatic Disposition | 180,56 - 190,15 | 545,47k | -1,80% |
| 2025-08-28 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -10,00k | 1,88M | Automatic Disposition | 185,93 - 190,79 | 555,47k | -1,77% |
| 2025-06-23 | Mr. Cary L. BakerCFO | 1,12k | 0,00 | Derivative Exercise and Retained Stock | - | 80,35k | 1,42% |
| 2025-06-23 | Mr. Cary L. BakerCFO | -732,00 | 77,84k | Derivative Exercise and Sale | 106,34 | 80,35k | - |
| 2025-06-23 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | 3,42k | 0,00 | Derivative Exercise and Retained Stock | - | 565,47k | 0,61% |
| 2025-06-23 | Dr. Chris DiorioCo-Founder, Vice Chair & CEO | -2,22k | 235,86k | Derivative Exercise and Sale | 106,34 | 565,47k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
